HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pnina Fishman Selected Research

N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosine

10/2007The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.
1/2006The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
3/2005Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
10/2003A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
10/2003A3 adenosine receptor agonist potentiates natural killer cell activity.
5/2003Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
6/2002Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
6/2002A3 adenosine receptor as a target for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pnina Fishman Research Topics

Disease

15Neoplasms (Cancer)
01/2019 - 04/2002
7Arthritis (Polyarthritis)
09/2016 - 03/2005
5Rheumatoid Arthritis
09/2016 - 01/2006
5Carcinoma (Carcinomatosis)
01/2005 - 06/2002
5Melanoma (Melanoma, Malignant)
10/2003 - 06/2002
3Inflammation (Inflammations)
12/2019 - 10/2007
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018 - 01/2016
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2013
2Reperfusion Injury
12/2019 - 11/2016
2Dry Eye Syndromes (Dry Eye Syndrome)
06/2013 - 07/2010
2Neoplasm Metastasis (Metastasis)
10/2002 - 04/2002
2Sarcoma (Soft Tissue Sarcoma)
10/2002 - 04/2002
1Erectile Dysfunction
10/2022
1Alcoholic Fatty Liver
12/2021
1Fatty Liver
12/2019
1Fibrosis (Cirrhosis)
12/2019
1Non-alcoholic Fatty Liver Disease
12/2019
1Cytokine Release Syndrome
01/2019
1Necrosis
11/2016
1Crohn Disease (Crohn's Disease)
09/2016
1Osteoarthritis
01/2014
1Glaucoma
06/2013
1Uveitis
11/2011
1Keratitis
07/2010
1Exanthema (Rash)
01/2008
1Nausea
01/2008
1Headache (Headaches)
01/2008
1Experimental Arthritis
03/2005
1Body Weight (Weight, Body)
03/2005
1Lymphatic Metastasis
07/2004
1Asthma (Bronchial Asthma)
01/2003
1Lymphoma (Lymphomas)
06/2002
1Multiple Sclerosis
04/2002
1Neurofibrosarcoma (MPNST)
04/2002

Drug/Important Bio-Agent (IBA)

22Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2022 - 06/2002
11CF101IBA
09/2016 - 04/2004
9Proteins (Proteins, Gene)FDA Link
09/2016 - 05/2003
8N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
10/2007 - 06/2002
5Pharmaceutical PreparationsIBA
09/2016 - 07/2010
5NF-kappa B (NF-kB)IBA
01/2007 - 05/2003
3Adenosine (Adenocard)FDA LinkGeneric
01/2014 - 06/2002
3Cyclin D1IBA
01/2005 - 10/2003
3Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
04/2004 - 06/2002
2TropomyosinIBA
09/2016 - 03/2005
2CollagenIBA
09/2016 - 10/2007
2Biological ProductsIBA
01/2013 - 01/2003
2Purinergic P1 Receptor AgonistsIBA
10/2007 - 03/2005
2purineIBA
10/2003 - 05/2003
2Interleukin-12 (IL 12)IBA
10/2003 - 10/2002
2ThymidineIBA
05/2003 - 04/2002
2Intravenous Immunoglobulins (IVIG)FDA Link
10/2002 - 04/2002
1ApomorphineFDA Link
10/2022
1Streptozocin (Streptozotocin)FDA Link
10/2022
1nasIBA
12/2019
1Alanine (L-Alanine)FDA Link
12/2019
1CarbonIBA
12/2019
1Protective AgentsIBA
12/2019
1LeptinIBA
12/2019
1AdiponectinIBA
12/2019
1Interleukin-17 (Interleukin 17)IBA
01/2018
1Interleukin-23 (Interleukin 23)IBA
01/2018
1CytokinesIBA
11/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2016
1Biomarkers (Surrogate Marker)IBA
09/2016
1Adenosine A3 ReceptorIBA
01/2016
1Concanavalin AIBA
01/2014
1N- (3,4- dichlorophenyl)- 2- cyclohexyl- 1H- imidazo(4,5- c)quinolin- 4- amineIBA
01/2014
1AntigensIBA
11/2011
1interstitial retinol-binding proteinIBA
11/2011
1Retinaldehyde (Retinal)IBA
11/2011
1Fluorescein (Funduscein)FDA LinkGeneric
07/2010
1Cell Surface ReceptorsIBA
01/2008
1Methotrexate (Mexate)FDA LinkGeneric
10/2007
1MitogensIBA
01/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005
1Phosphotransferases (Kinase)IBA
01/2005
1Fluorouracil (Carac)FDA LinkGeneric
01/2005
1BromidesIBA
01/2005
1Caspase 3 (Caspase-3)IBA
01/2005
1ParaffinIBA
07/2004
1Messenger RNA (mRNA)IBA
07/2004
1Glycogen Synthase Kinase 3IBA
04/2004
1Glycogen Synthase (Synthase I)IBA
04/2004
12,3- diethyl- 4,5- dipropyl- 6- phenylpyridine- 3- thiocarboxylate- 5- carboxylateIBA
10/2003
1AndrogensIBA
05/2003
1Cytostatic AgentsIBA
01/2003
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2002
1Glycogen Synthase Kinase 3 betaIBA
06/2002
1Glycogen Synthase KinasesIBA
06/2002
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2002
1beta CateninIBA
06/2002
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2002

Therapy/Procedure

5Therapeutics
10/2007 - 06/2002
1Drug Therapy (Chemotherapy)
12/2019
1Immunotherapy
01/2019
1Hepatectomy
11/2016
1Oral Administration
06/2013